896 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
3 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
4 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
5 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
6 Recruiting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
Condition: Primary Lung Cancer
Intervention:
7 Recruiting Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: pemetrexed disodium
8 Recruiting Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted Therapy
Condition: Non Small Cell Lung Cancer
Intervention:
9 Recruiting Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 and Nab®-Paclitaxel Monotherapy as Second Line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: nab-paclitaxel IV;   Drug: CC-486
10 Recruiting Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: EGF816;   Drug: INC280;   Drug: Nivolumab
11 Recruiting A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer
Interventions: Drug: MEK162;   Drug: Erlotinib
12 Recruiting Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies
Conditions: Non-Small Cell Lung Cancer, Small Cell Lung Cancer;   Platinum Responsive Malignancies
Interventions: Drug: KML-001;   Drug: Cisplatin
13 Recruiting Ipilimumab Plus Targeted Inhibitor (Erlotinib or Crizotinib) for EGFR or ALK Mutated Stage IV Non-small Cell Lung Cancer: Phase Ib With Expansion Cohorts
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Ipilimumab;   Drug: Erlotinib;   Drug: Crizotinib
14 Recruiting A Study of MPDL3280A Compared With Gemcitabine + Cisplatin or Carboplatin in Patients With Stage IV Squamous Non-Small Cell Lung Cancer
Condition: Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Carboplatin;   Drug: Cisplatin;   Drug: Gemcitabine;   Drug: MPDL3280A
15 Recruiting Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention:
16 Recruiting MSC2156119J With Gefitinib in Subjects With Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: MSC2156119J;   Drug: Gefitinib;   Drug: Pemetrexed;   Drug: Cisplatin
17 Unknown  Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
Interventions: Drug: cisplatin, vinorlebine, cetuximab;   Drug: cisplatine, etoposide, cetuximab
18 Recruiting Improving Resection Rates Among African Americans With NSCLC
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Other: Usual Care;   Other: Intervention Arm
19 Recruiting A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Radiation: Stereotactic Body Radiation Therapy plus Surgery
20 Recruiting Metformin in Non Small Cell Lung Cancer (NSCLC)
Condition: Lung Cancer
Interventions: Drug: Metformin;   Other: Placebo;   Radiation: Stereotactic body Radiotherapy (SBRT)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years